BioMind is an AI medical technology company headquartered in Beijing with subsidiaries in Singapore and Europe. The company co-established the world's first AI research center for neurological diseases (CHAIN) with Beijing Tiantan Hospital and maintains strategic partnerships with MIT AI Lab and National University of Singapore. Products span medical imaging, pathology diagnosis, treatment planning, drug development, radiotherapy, and rehabilitation, with multiple NMPA-approved systems deployed globally.